RecruitingNCT06820515

ATHNdataset Registry

Studying Glanzmann thrombasthenia

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: American Thrombosis and Hemostasis Network
Principal Investigator: Tammuella Chrisentery-Singleton, M.D.
American Thrombosis and Hemostasis Network
Enrollment: 200000 enrolled
Eligibility: All sexes
Timeline: 2024 – 2055

Study locations (1)

American Thrombosis and Hemostasis Network, Hickory, North Carolina, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06820515 on ClinicalTrials.gov

Other trials for Glanzmann thrombasthenia

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07136857
Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
Emory University
RECRUITINGNANCT04119908
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
University Hospital, Lille
ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06211634
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
Hemab ApS
RECRUITINGNCT00230165
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Rockefeller University

See all trials for Glanzmann thrombasthenia →

← Back to all trials